Norfenefrine in the treatment of female urinary stress incontinence assessed by one-hour pad weighing test.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/2568712
Conclusion of this study
Thirty-three women with urinary stress incontinence were treated with the alpha-adrenoceptor-stimulating agent, norfenefrine (Nevadral Retard). Treatment was administered during 3-24 weeks at a daily dosage of 90 mg. Judged by a 1-hour pad weighing test, a significant effect could be demonstrated. With the exception of 1 case of allergic reaction and 1 case of recurrent vomiting, a simultaneously performed tolerability test revealed only minor side effects.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study